1233335-78-8 Usage
Uses
Used in Hepatitis C Treatment:
Sofosbuvir metabolites GS566500 are used as an intermediate in the conversion of sofosbuvir to its active form, which is essential for the treatment of hepatitis C virus infections. The metabolites contribute to the drug's therapeutic effectiveness by enhancing its antiviral activity and reducing the viral load in infected patients.
Used in Pharmaceutical Research and Development:
Understanding the formation, metabolism, and elimination of GS566500 is crucial for optimizing the use of sofosbuvir in the treatment of hepatitis C virus infections. Researchers and pharmaceutical companies utilize this knowledge to develop more effective and safer antiviral medications, as well as to improve the pharmacokinetic and pharmacodynamic properties of existing drugs.
Used in Drug Metabolism Studies:
Sofosbuvir metabolites GS566500 serve as a model for studying drug metabolism and the role of metabolites in the pharmacokinetics and pharmacodynamics of medications. This information is valuable for predicting the behavior of other prodrugs and their metabolites, as well as for designing new drugs with improved efficacy and reduced side effects.
Used in Toxicology and Safety Assessment:
The study of GS566500 metabolites also plays a role in toxicology and safety assessment of sofosbuvir. By understanding the potential side effects and toxicological properties of these metabolites, researchers can better evaluate the safety profile of the drug and identify strategies to minimize adverse effects in patients.
Check Digit Verification of cas no
The CAS Registry Mumber 1233335-78-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,3,3,3 and 5 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1233335-78:
(9*1)+(8*2)+(7*3)+(6*3)+(5*3)+(4*3)+(3*5)+(2*7)+(1*8)=128
128 % 10 = 8
So 1233335-78-8 is a valid CAS Registry Number.
1233335-78-8Relevant articles and documents
NUCLEOSIDE ANALOGS
-
Page/Page column 32-33, (2010/07/09)
A purified compound having activity against hepatitis C virus is disclosed.